Expert Analysis

Resistance and Management of Treatment-Experienced Patients

Source: CCO Official Conference Coverage of the 2006 International AIDS Conference

Resistance and Management of Treatment-Experienced Patients

Faculty:

Charles Boucher, MD, PhD
Kathleen E. Squires, MD
Mark A. Wainberg, PhD

Andrew R. Zolopa, MD

CREDIT INFORMATION

Release Date: 09/29/06

Expiration Date: 09/28/07

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.2 Nursing contact hours

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss studies regarding the transmission of drug-resistant HIV
Describe recent data on the use of darunavir/ritonavir in treatment-experienced patients
Review new findings regarding the contribution of NRTIs and NNRTIs to virologic suppression in triple-class–experienced patients

Topics covered include:

Transmission of HIV Drug Resistance
Darunavir for Treatment-Experienced Patients
I50L in Patients Failing Atazanavir-Containing Regimens
Lamivudine Monotherapy in Patients With M184V
Role of NRTIs and NNRTIs in Treatment-Experienced Patients

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.